Humatech (HUMT) Stock Price
Humatech Price
Humatech stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Humatech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Humatech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Humatech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Humatech Price |
|---|---|
| 2/16/2026 | 0.00 USD |
| 2/9/2026 | 0.00 USD |
Humatech Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Humatech Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (k USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2001 | 2002 | 2003 | 2004 | 2005 | 2006 |
|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 1,000 |
| – | – | – | – | – | – |
| – | – | – | – | – | - |
| 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | -2 | -2 | -1 | -1 | 0 |
| – | – | – | -50.00 | – | – |
| 9.57 | 13.01 | 16.52 | 23.02 | 31.91 | 34.28 |
| – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Humatech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humatech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humatech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Humatech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humatech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Unlock the full history with 30+ years of data and forecast estimates.
Unlock all data — PROHumatech Stock Quarterly Figures
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| 2006 Q1 | 2006 Q2 | 2006 Q3 | 2006 Q4 | 2007 Q1 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 |
| – | – | – | – | – |
| – | – | – | – | – |
| 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 |
| – | – | – | – | – |
| 34.01 | 34.12 | 34.3 | 34.66 | 36.35 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Humatech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humatech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humatech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Humatech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humatech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Unlock the full history with 30+ years of data and forecast estimates.
Unlock all data — PROHumatech stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Humatech Stock Sales Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Humatech business model
Humatech SWOT Analysis
Strengths
Humatech Inc has built a strong reputation in the industry over the years, gaining the trust and loyalty of customers.
With a diverse range of innovative products, Humatech Inc remains competitive and meets the evolving needs of the market.
Humatech Inc invests heavily in research and development, allowing them to stay at the forefront of technology advancements and maintain a competitive advantage.
Weaknesses
Although Humatech Inc has a strong presence in its domestic market, it lacks significant global reach, potentially limiting growth opportunities.
Humatech Inc relies heavily on a few key suppliers, which exposes them to risks such as supply disruptions and potential price fluctuations.
The extensive investments in research and development impose significant costs on Humatech Inc, affecting profitability in the short term.
Opportunities
Humatech Inc can expand its market presence by targeting emerging markets with growing demand for their products.
Collaborating with strategic partners can help Humatech Inc access new technologies, markets, and resources, driving further growth and innovation.
With increasing environmental concerns, Humatech Inc can capitalize on the growing demand for sustainable solutions and align their products accordingly.
Threats
The industry is highly competitive, with several players vying for market share, which can pose challenges for Humatech Inc's growth and profitability.
Stringent regulations and compliance requirements in the industry may limit Humatech Inc's operations or increase costs.
Fluctuations in the global economy and financial markets can impact customer spending and demand for Humatech Inc's products.
Humatech Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Humatech historical P/E ratio, EBIT multiple, and P/S ratio
Humatech shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Humatech shareholders
| % | Name |
|---|---|
% |
Humatech Executives and Management Board
David Williams
(59)President, Chief Executive Officer, Director
John Rottweiler
(63)Chief Financial Officer, Secretary, Director
Humatech Research
SoonDeep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.
Research reports are coming soon
We're building institutional-grade equity research for Humatech and thousands of other companies.
Most common questions regarding Humatech
The business model of Humatech Inc revolves around the manufacturing and distribution of innovative medical devices for the healthcare industry. Humatech Inc specializes in developing cutting-edge technologies that cater to various medical needs, ensuring sustainable solutions for patients and healthcare providers globally. With a strong focus on research and development, the company aims to improve patient outcomes and enhance medical procedures. By consistently delivering high-quality products and maintaining strong relationships with healthcare professionals, Humatech Inc continues to thrive in the competitive healthcare market.
Humatech stock
Humatech Peer Group
Humatech Ticker
Humatech FIGI
All fundamentals about Humatech
Our stock analysis for Humatech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humatech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.